FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients

NCT00090051 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

552

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

DRUG: Rituximab
DRUG: Fludarabine Phosphate
DRUG: Cyclophosphamide

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]
[object Object]